BA
CTSO icon

BlackRock Advisors’s Cytosorbents Corp CTSO Stock Holding History

BlackRock Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23K Hold
4,303
– – ﹤0.01% 3425
2016
Q3 		$28K Buy
4,303
+3,439
+398% +$17.9K ﹤0.01% 3382
2016
Q2 		$4K Hold
864
– – ﹤0.01% 3686
2016
Q1 		$3K Hold
864
– – ﹤0.01% 3714
2015
Q4 		$5K Buy
+864
New +$5.88K ﹤0.01% 3716

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

BlackRock Advisors's CTSO Position: Q4 2016 in Review

BlackRock Advisors held its Cytosorbents Corp (CTSO) position steady in Q4 2016 at 4,303 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3425.

BlackRock Advisors first reported a position in CTSO in Q4 2015 and has held it in 5 quarters since. The position peaked at $28K in Q3 2016. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

  • BlackRock Advisors held 4,303 shares of Cytosorbents Corp worth $23K as of Q4 2016.
  • BlackRock Advisors left its Cytosorbents Corp share count unchanged in Q4 2016.
  • Cytosorbents Corp made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3425 holding.
  • BlackRock Advisors first reported a position in Cytosorbents Corp in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Cytosorbents Corp position peaked at $28K in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.